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? In humans, the skin blood flow (SkBF) response to a non-painful, rapid heat stimulus consists of two phases: an initial peak 
followed by a secondary rise and plateau (Figure 1C; Kellogg et al., 1999). 
? The magnitude of both these phases is diminished with advanced age (Minson et al., 2002), potentially making the elderly 
more susceptible to local tissue damage in response to directly applied heat. 
? The mechanisms underpinning the age-related decline in the initial peak are unclear.
? Sensory nerves are known to contribute to the initial peak (Minson et al., 2001).
? We investigated whether the age-related decline in the initial peak was due to diminished sensory nerve function 
and whether habitual aerobic exercise prevents this age-related decrement.
? The lower control-site initial peak responses of the older untrained group suggest that sedentary ageing is associated with an 
increased risk of local tissue damage when heat is directly applied to the skin surface. 
? These lower responses appeared to be explained by diminished sensory nerve-mediated vasodilatation, because the initial 
peak did not differ between groups at sites pre-treated with EMLA cream. 
? Our findings also suggest that sensory nerve-mediated cutaneous vasodilator function can be preserved into advanced age 
by participating in regular aerobic exercise training.
REFERENCES: Kellogg et al. (1999) J Appl Physiol 86 1185-1190; Minson et al. (2001) J Appl Physiol 91 1619-1626; Minson et al. (2002) J Appl Physiol 93 1644-1649
4. Discussion
1. Introduction
? Using laser Doppler flowmetry, we measured SkBF at baseline 
and during 35 min of local heating (42°C; Figure 1) at two 
forearm sites in young and older endurance-trained and 
untrained men (Table).
? One skin site was pre-treated with topical local anaesthetic 
cream (EMLA) to block local sensory innervations (Figure 1A).
? SkBF was expressed as cutaneous vascular conductance 
(CVC: SkBF/mean arterial pressure) and indexed to a 
percentage of maximum (%CVCmax) obtained via local 
heating to 44°C. 
? Analysis: Two-factor (group × condition), mixed-model 
ANOVAs with Tukey post-hoc tests. Data are means ± SEM 
and significance was set at P ≤ 0.05.
2. Methods
3. Results
Table. Participant characteristics and SkBF data
? At the control site, the initial peak was lower in the older 
untrained group compared to all other groups, both when 
expressed as raw CVC (Table) and %CVCmax (Figure 2).
? Sensory nerve blockade decreased the initial peak in all 
groups such that there were no between-group differences at 
the EMLA-treated site (Table & Figure 2).
Figure 2. Initial peak CVCmax data for control and EMLA-treated sites. 
*versus all other groups (P < 0.05); †versus control site (P < 0.05)
Variable Young trained
(n = 7)
Young untrained
(n = 7)
Older trained
(n = 7)
Older untrained
(n = 7)
Age (years) 24 ± 1 25 ± 1 64 ± 1* 64 ± 1*
Body mass (kg) 78 ± 4 75 ± 7 77 ± 3 85 ± 4
Stature (cm) 180 ± 1 179 ± 2 175 ± 2 179 ± 3
VO2max (mL·kg-1·min-1) 58 ± 3† 40 ± 2 44 ± 2 28 ± 2†
Control initial peak CVC 2.86 ± 0.30 2.09 ± 0.21 2.19 ± 0.25 1.88 ± 0.12†
EMLA initial peak CVC 1.51 ± 0.29 1.50 ± 0.16 1.52 ± 0.19 1.33 ± 0.12
Control maximum CVC 3.76 ± 0.34† 2.82 ± 0.29 2.71 ± 0.34 2.75 ± 0.13
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Figure 1. Experimental set-up: A, EMLA cream application for 90 min; 
B, Integrated laser Doppler flowmetry probes at EMLA and control sites; 
C, Typical %CVCmax responses during 35 min of local heating at 42°C.
B
*versus young groups (P < 0.05); †versus all other groups (P < 0.05)
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